NASDAQ : BGMS
Bio Green Med Solution, Inc. — Key statistics
Healthcare · Biotechnology · Malaysia
Last price 0.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.96M |
| Enterprise Value | 2.17M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.62M |
| Shares Outstanding | 6.62M |
| Shares Change (YoY) | +186.01% |
| Shares Change (QoQ) | +2.57% |
| Owned by Insiders (%) | 19.81% |
| Owned by Institutions (%) | 2.71% |
| Float | 5.31M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.20 |
| Forward PS | n/a |
| PB Ratio | 0.83 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.63 |
| Quick Ratio | 7.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 34.40% |
| Return on Assets (ROA) | -37.01% |
| Return on Invested Capital (ROIC) | -104.37% |
| Return on Capital Employed (ROCE) | -50.66% |
| Weighted Average Cost of Capital (WACC) | 2.15% |
| Revenue Per Employee | $155,083 |
| Profits Per Employee | -$1.11M |
| Employee Count | 12 |
| Asset Turnover | 0.30 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 44,000 |
| Effective Tax Rate | 2.32% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.38 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.90 |
| 200-Day Moving Average | 0.97 |
| Relative Strength Index (RSI) | 48.93 |
| Average Volume (20 Days) | 34,658 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 30,190 |
| Short Previous Month | 5,591 |
| Short % of Shares Out | 0.46% |
| Short % of Float | 0.57% |
| Short Ratio (days to cover) | 0.58 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.86M |
| Gross Profit | -451,000 |
| Operating Income | -3.63M |
| Pretax Income | 1.90M |
| Net Income | -13.32M |
| EBITDA | -3.62M |
| EBIT | -3.63M |
| Loss Per Share | -$2.94 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.79M |
| Total Debt | n/a |
| Net Cash | 3.79M |
| Net Cash Per Share | $0.57 |
| Equity (Book Value) | 7.16M |
| Book Value Per Share | 1.08 |
| Working Capital | 5.28M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -1.10M |
| Capital Expenditures | -1,000 |
| Depreciation & Amortization | 5,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -1.10M |
| FCF Per Share | -$0.17 |
Margins
| Measure | Value |
|---|
| Gross Margin | -24.23% |
| Operating Margin | -194.95% |
| Pretax Margin | 102.10% |
| Profit Margin | -118.27% |
| EBITDA Margin | -194.68% |
| EBIT Margin | -194.95% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -186.01% |
| Shareholder Yield | -186.01% |
| Earnings Yield | -326.57% |
| FCF Yield | -18.42% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 440.69% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -74.14 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |